West Pharmaceutical Services WST Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Proprietary Products | $2.49B+6.8% | $2.33B-2.6% | $2.4B— | —— | |
| Other segment expense (income) by Business | |||||
| Proprietary Products | $21.1M-4.5% | $22.1M+48.3% | $14.9M+777% | -$2.2M— | |
| Total Assets by Business | |||||
| Proprietary Products | $11.43B— | —— | —— | —— | |
| Operating Income (Loss) by Business | |||||
| Proprietary Products | $657.2M+13.7% | $577.8M-18.6% | $710.1M— | —— | |
| Selling, general and administrative expenses by Business | |||||
| Proprietary Products | $255.6M+10.4% | $231.5M-3.8% | $240.6M+13.2% | $212.6M— | |
| Cost of goods and services sold by Business | |||||
| Proprietary Products | $1.48B+3.5% | $1.43B+5.2% | $1.36B+0.7% | $1.35B— | |
| Foreign currency translation by Business | |||||
| Contract-Manufactured Products | $700K+275% | -$400K-300% | $200K+150% | -$400K0.0% | |
| Proprietary Products | $3.8M+281% | -$2.1M-310% | $1M+145% | -$2.2M+8.3% | |
| Capital Expenditures by Business | |||||
| Proprietary Products | $204.3M-17.1% | $246.5M-4.9% | $259.1M+9.2% | $237.3M+8.9% | |
| R&D by Business | |||||
| Proprietary Products | $74.3M+7.5% | $69.1M+1.0% | $68.4M+16.9% | $58.5M— | |
| Depreciation and Amortization by Business | |||||
| Proprietary Products | $140.2M+7.6% | $130.3M+15.4% | $112.9M+16.5% | $96.9M+3.3% | |
| Concentration risk, percentage by Product | |||||
| Standard Packaging | 55%+7.0pp | 48%-9.0pp | 57%+5.0pp | 52%0.0pp | |
| Net Sales by Geography | |||||
| Other European countries | $451M+17.0% | $385.5M-0.7% | $388.1M+8.0% | $359.2M+5.2% | |
| Other | $353.3M+4.2% | $339M-2.7% | $348.5M-4.3% | $364.3M+1.9% | |
| Concentration risk, percentage by Geography | |||||
| Asia Pacific | 25%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
